Log inSign up
Image
user avatar
Eric Secemsky MD MSc
@EricSecemskyMD
Interventional Cardiologist/Director of Vascular Intervention | Outcomes Researcher | Associate Prof of Med | Proud Father and Husband | Opinions my own
Born January 30
Joined August 2017
1,254
Following
4,652
Followers
  • Pinned
    user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Aug 8, 2022
    1/Today published in @JACCJournals is the 1st global consensus document on IVUS use for lower ext arterial & venous revasc. This document involved >40 international multidisciplinary experts in vascular disease & was led by a 12 person steering committee. bit.ly/3A7bcTY
    Image
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Nov 28, 2023
    Great day advancing hypertension treatment! We did 2 commercial Spyral renal denervation cases for patients who have been struggling with BP control and mediation intolerance for years. Tears by both afterwards. Exciting times! @BIDMChealth @BidmcCvi @SmithBIDMC @SCAI @HyperAHA
    Image
    29K
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Mar 29, 2018
    Our Letter to the Editor for this recent JACC article, not accepted for publication: onlinejacc.org/content/71/8/8… Immortal time bias continues to be a pervasive issue w/observational studies. We have been doing our best to bring attention to this issue (see ja.ma/2uti4er).
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Dec 10, 2020
    PACLITAXEL TWEETORIAL 1/Brief tweetorial to provide context of the importance of today's NEJM paper showing no mortality difference at 1-4 years between patients with peripheral artery disease treated with paclitaxel-coated (PCD) & non-coated devices. nejm.org/doi/full/10.10…
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Jul 16, 2023
    If you’re going to promote exercise therapy for PAD, then make sure you provide it. After CMS coverage, <1.5% of claudicants had claims for SET. We started 5 centers in ‘18 bc few existed in Boston. Its easy to tell people to stop smoking & exercise, its harder to help them do it
    Image
    Image
    Image
    24K
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Jul 11, 2023
    >4 years after the Katsanos meta-analysis & the PTX controversy comes to an end. Proud professional moment to have contributed to navigating this controversy. Congrats to @US_FDA @FDADeviceInfo for getting this right. This important case will be remembered.shorturl.at/rzVY7
    user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Dec 10, 2020
    PACLITAXEL TWEETORIAL 1/Brief tweetorial to provide context of the importance of today's NEJM paper showing no mortality difference at 1-4 years between patients with peripheral artery disease treated with paclitaxel-coated (PCD) & non-coated devices. nejm.org/doi/full/10.10…
    Image
    34K
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    May 1, 2020
    Never know what ur going to get in a stemi. Here’s a 2am “find the missing vessel” (hint not the LAD). If good story always triple check ur angio ⁦@mnyoung1⁩ ⁦@rushiparikh11⁩ ⁦@hectortamezmd⁩ ⁦@MarieF_Poulin⁩ ⁦⁦@sanjum⁩ ⁦⁦⁦@marktuttle⁩
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Jan 26, 2021
    Sick massive PE s/p systemic lysis. Residual shock w/blown RV, 2 pressors & rising lactate. Fast work by our @PERTConsortium team. Brought to lab for RHC & PAgram. PAPI 0.7. Team Felt residual right PE too distal for extraction. ProtectDuo placed for RV support. Great teamwork.
    Image
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Jul 23, 2020
    1/Couldn't be more thankful for this opportunity from the @nih_nhlbi . Honestly, as much as the K award is focused on the investigator, this was a major team effort from my amazing colleagues @SmithBIDMC. I aim to use this award to find better ways to inform & consult our PAD pts
    user avatar
    Robert W. Yeh
    @rwyeh
    Jul 23, 2020
    Going to embarrass @EricSecemskyMD here, but this is too good not to share. His NHLBI K23 was officially awarded today. Quickly becoming THE PAD triple threat. @SmithBIDMC @BidmcCvi
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    May 7, 2020
    Great ⁦@ShockwaveIVL⁩ case. This type of iliac disease keeps me up at night. Using a 7mm IVL balloon at 4 ATM is a game changer. ⁦@SDhandMD⁩ ⁦@JayMathewsMD⁩ ⁦@HadyLichaaMD⁩ ⁦@Vascularman⁩ ⁦@sahilparikhmd⁩ ⁦@sanjum⁩ ⁦⁦@JimGMelton⁩
    Image
    Image
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Oct 19, 2022
    Use IVUS @sahilparikhmd @sanjaydivakaran @PVDMD @monteleoneMD @krosenfieldMD @SDhandMD @AmputationSuck @kmadass @JACCJournals @daveed333 @docmrjaff @HadyLichaaMD @kush_r_desai @JRUNMD @drseanlyden @VIVAPhysicians jacc.org/doi/10.1016/j.…
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Nov 7, 2022
    Lots to digest from BEST-CLI. My early take - if most events are close to day 0, need to be thoughtful of interpretation. Agree that if good vein & suboptimal anatomical characteristics for endo, then bypass reasonable. But many events driven by immediate crossover or repeat PVI
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Aug 13, 2020
    Phenomenal 1st @InariMedical case. 90+ yo, prior SAH, massive PE, tubed in ED & pressors. Sa02 60% on Fi02 100%. PERT call->cath lab. Needed a lil local tPA as some chronic clot, but got a few big clots. Sa02 100% after. Big thx to IR buddy #JeffWeinstein & guest star @duanepinto
    Image
    Image
    Image
  • user avatar
    Eric Secemsky MD MSc
    @EricSecemskyMD
    Nov 18, 2020
    3+ antihypertensives, recent HF admission, occluded left renal, creat 1.8. Still a role for renal artery stenting. Telescoped in & then 6x15mm Herculink w/@WallyOmarMD. In the future, I plan to denervate all these first and then stent... @BaoGTran @HadyLichaaMD @JayMathewsMD
    Image
    Image